Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
Lipton RB, Varon SF, Grosberg B, McAllister PJ, Freitag F, Aurora SK, Dodick DW, Silberstein SD, Diener HC, DeGryse RE, Nolan ME, Turkel CC. Lipton RB, et al. Among authors: dodick dw. Neurology. 2011 Oct 11;77(15):1465-72. doi: 10.1212/WNL.0b013e318232ab65. Epub 2011 Sep 28. Neurology. 2011. PMID: 21956721 Clinical Trial.
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group. Aurora SK, et al. Among authors: dodick dw. Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17. Cephalalgia. 2010. PMID: 20647170 Clinical Trial.
Migraine prevention.
Dodick DW, Silberstein SD. Dodick DW, et al. Pract Neurol. 2007 Nov;7(6):383-93. doi: 10.1136/jnnp.2007.134023. Pract Neurol. 2007. PMID: 18024778 Review.
Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine.
Silberstein SD, Dodick DW, Lindblad AS, Holroyd K, Harrington M, Mathew NT, Hirtz D; Chronic Migraine Treatment Trial Research Group. Silberstein SD, et al. Among authors: dodick dw. Neurology. 2012 Mar 27;78(13):976-84. doi: 10.1212/WNL.0b013e31824d5846. Epub 2012 Feb 29. Neurology. 2012. PMID: 22377815 Free PMC article. Clinical Trial.
Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.
Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Silberstein SD, et al. Among authors: dodick dw. Neurology. 2012 Apr 24;78(17):1337-45. doi: 10.1212/WNL.0b013e3182535d20. Neurology. 2012. PMID: 22529202 Free PMC article. Review.
Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.
Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Holland S, et al. Among authors: dodick dw. Neurology. 2012 Apr 24;78(17):1346-53. doi: 10.1212/WNL.0b013e3182535d0c. Neurology. 2012. PMID: 22529203 Free PMC article. Review.
487 results